Nodular sclerosis Hodgkin lymphoma, unspecified site digital illustration

Nodular sclerosis Hodgkin lymphoma, unspecified site Save


ICD-10 code: C81.10

Disease category: C81.1: Nodular sclerosis Hodgkin lymphoma

Nodular Sclerosis Hodgkin Lymphoma: Unspecified Site

Nodular sclerosis Hodgkin lymphoma (NSHL) is a subtype of Hodgkin lymphoma, a type of cancer that affects the lymphatic system. NSHL is the most common subtype, accounting for about 60-80% of all Hodgkin lymphoma cases. It primarily affects adolescents and young adults, with a slight female predominance.

Although NSHL can occur in various sites within the body, the term "unspecified site" refers to cases where the exact location is not specified. This could be due to the lymphoma being present in multiple lymph nodes or an atypical location that is not easily categorized.

NSHL is characterized by the presence of nodules or bands of fibrous tissue, known as sclerosis, which divide the affected lymph nodes. The Reed-Sternberg cells, large abnormal cells that are a hallmark of Hodgkin lymphoma, are present within these nodules. The presence of these cells, along with other specific characteristics, helps in the diagnosis of NSHL.

  1. Symptoms: Common symptoms of NSHL include painless swelling of lymph nodes, usually in the neck, armpits, or groin. Other possible symptoms include fatigue, fever, night sweats, and unexplained weight loss. However, it's important to note that the presence of these symptoms does not necessarily indicate NSHL, as they can be caused by various other conditions.
  2. Diagnosis: To diagnose NSHL, a series of tests may be performed, including physical examination, blood tests, imaging studies (such as CT scan or PET scan), and biopsy of the affected lymph node. The biopsy helps to determine the presence of Reed-Sternberg cells and the characteristic histological features of NSHL.
  3. Prognosis: The prognosis for NSHL is generally favorable, with a high cure rate. The specific treatment plan will depend on various factors, including the stage of the disease, the patient's age, and overall health. Treatment options may include chemotherapy, radiation therapy, or a combination of both.

It's essential to consult a healthcare professional for an accurate diagnosis and appropriate treatment plan for NSHL. Early detection and timely intervention can significantly improve the outcomes for individuals with this type of lymphoma. Regular follow-ups and ongoing medical care are crucial for long-term management and monitoring of the disease.

Remember, this article provides general information about nodular sclerosis Hodgkin lymphoma, unspecified site, and should not be used as a substitute for professional medical advice. Always consult your healthcare provider for personalized guidance.

Treatment of Nodular sclerosis Hodgkin lymphoma, unspecified site:

Treatment Options for Nodular Sclerosis Hodgkin Lymphoma, Unspecified Site

Nodular sclerosis Hodgkin lymphoma (NSHL) is a type of Hodgkin lymphoma, a cancer that affects the lymphatic system. NSHL is the most common subtype, accounting for about 70% of all Hodgkin lymphoma cases. When diagnosed with NSHL, it is crucial to understand the available treatment options to make informed ...

To see full information about treatment please Sign up or Log in